arrow
Y

Yanink Caro-Vega

instituto nacional de ciencias médicas y nutricion salvador zubiran
H指数:11
被引数:443

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Evolution of ART Medication Adherence Support and Monitoring Across IeDEA Sites: Results From Three Waves of Consortium-Wide Site Assessment Surveys, 2017, 2020 and 2023

抗逆转录病毒疗法药物依从性支持与监测的演变:基于IeDEA联盟三次大规模站点评估调查的结果,2017年、2020年和2023年

2026-09-050
OAAI
Sex Differences in Advanced HIV Disease at Presentation in Care Among People Living With HIV in Latin America and the Caribbean

在拉丁美洲和加勒比地区,人类免疫缺陷病毒感染者中,在开始接受治疗时,晚期艾滋病的性别差异

2026-08-140
OAAI
Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trial

吡啶斯的明降低严重SARS-CoV-2感染患者的死亡率: 一项2/3期随机对照试验

2022-11-087
OAAI
A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocol
2020-10-169
OAAI
The influence of hospital antimicrobial use on carbapenem-non-susceptible Enterobacterales incidence rates according to their mechanism of resistance: a time-series analysis
2020-08-015
PREAI
Differences in response to antiretroviral therapy in HIV-positive patients being treated for tuberculosis in Eastern Europe, Western Europe and Latin America
2018-04-234
OAAI